IXC invex therapeutics ltd

Ann: Invex to close IIH Evolve Phase III Clinical Trial, page-5

  1. 428 Posts.
    lightbulb Created with Sketch. 60
    Not unexpected. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. At least we have some clarity on the pathway forward.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.0¢
Change
0.002(2.27%)
Mkt cap ! $6.763M
Open High Low Value Volume
8.8¢ 9.0¢ 8.8¢ $8.48K 95K

Buyers (Bids)

No. Vol. Price($)
1 42086 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 11.50am 18/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.